SBI honours policemen

Bengaluru, Jun 23: Former Karnataka Chief Minister HD Kumaraswamy on Tuesday demanded that Bengaluru should be put under lockdown for 20 days to contain the spread of coronavirus, the cases of which have risen sharply recently.

 “Stop playing with people's lives. There’s no use in sealing off only some areas. If the people of Bengaluru must live, then a lockdown of at least 20 days is needed. Otherwise, Bengaluru will become another Brazil,” Kumaraswamy said in a tweet. “People’s health is more important, not economy.”

The JD(S) leader was reacting to the BJP government's decision to impose an area-wide lockdown in Chickpet, KR Market, Kalasipalyam and Chamarajpet while streets will be sealed off in VV Puram, Siddapura, Yelahanka, Vidyaranyapura and Chickpet.

Bengaluru has witnessed a huge spike in its Covid-19 tally; the city currently has at least 919 active cases. This has sparked off fears that the contagion might have reached the community.

Kumaraswamy has also demanded welfare measures for the poor. “The poor and the labourers should be given ration immediately. The state’s 50 lakh working class should get ₹5,000 each. The aid already announced by the government hasn’t reached drivers, weavers, Madiwalas and other communities,” he said, adding that mere announcements of a package won’t be enough and “it has to be implemented.”

Bengaluru, July 17: A 60-year-old woman who tested positive for Covid-19 allegedly ended her life in the Covid ward at KC General Hospital in the early hours of Friday.

The woman, the fourth Covid positive patient to end her life since April, was a resident of Mariyappanapalya near Jnanabharathi in West Bengaluru. She was found hanging from a window grille in the passage of the Covid ward around 5 am. She had used her sari to hang herself.

The police said that the woman was admitted to the hospital on July 1. She was responding well to the treatment and was almost cured. Her son was infected first and admitted to the same hospital. As she later tested positive and got admitted, her son was discharged on July 11. The police suspect that the woman may have resorted to the extreme step due to depression.

An investigating officer quoted doctors telling the police that they were about to inform the woman about her discharge date on Friday. Doctors were waiting for the report on her latest test before discharging her.

The woman’s body will be subjected to an autopsy as per the Covid standard procedure. The Malleswaram police have taken up a case of unnatural death. Investigations are on. 

On July 11, a 70-year-old man ended his life in the toilet of the Covid ward in Victoria Hospital, while a suicide was reported in the same ward on June 26. A 60-year-old woman also hanged herself in the toilet. Her son, daughter-in-law, and grandson were also admitted to hospital for Covid-19.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.